How future with lower Covid death rate seems like a worthy investment

Q: How long will it take to read this news story?

The story "How future with lower Covid death rate seems like a worthy investment" has 1318 words across 60 sentences, which will take approximately 6 - 11 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "How future with lower Covid death rate seems like a worthy investment" was covered 1 months ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of . It's most recent story was published 6 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #4928393</li><li>URL: https://beamstart.com/news/how-future-with-lower-covid-16750020754369</li></ul>

Business Standard Logo Business Standard 1 mo ago

How future with lower Covid death rate seems like a worthy investment - Business Standard

Quick Summary:

Unfortunately, turning nasal vaccines into reality has a long way to go.

During last week’s FDA advisory meeting, frustration was palpable that we continue to employ a strategy that relies on chasing variants with updated boosters, ones that we know provide only a modest improvement over earlier shots, and offer a limited window of protection at that.

All of that will likely require large, complex trials — ones that might be even more expensive and take far longer to run than the ones that got us the current vaccines.